Hemostats Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Hemostats Market to 2027 - Global Analysis and Forecasts By Product (Thrombin Based Hemostats, Combination Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Gelatin Based Hemostats, and Collagen Based Hemostats); End User (Hospitals & Clinics, Ambulatory Surgical Centers and Others) and Geography

Report Code: TIPHE100001419 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION
Hemostat is a surgical tool used to control bleeding in the surgical process. Hemostats are used by means of tissue sealants and tissue adhesion agents. These products are nowadays replacing conventional sutures for wound and incision closure. The tissue adhesives, tissue sealants, and related products has advantages such as application of minimal invasion, better visualization, reduced operating time, prevention of leakage of non-blood fluids and reduced post-operative infection risks and hence reduction in hospital stays and overall medical costs.

MARKET DYNAMICS
The hemostats market is expected to grow significantly due to various factors such as, Rise in healthcare insurance providers, technological advancement and growing number of surgery procedures. Moreover, Rise in the untapped emerging nations and increased initiatives take up by governments are expected to fuel the growth of this market during the forecast period.

MARKET SCOPE
The "Global Hemostats Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global hemostats market with detailed market segmentation by product, end user and geography. The global hemostats market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global hemostats market is segmented on the basis of product, and end user. Based on product, the hemostats market is categorized as, thrombin based hemostats, combination hemostats, oxidized regenerated cellulose based hemostats, gelatin based hemostats, and collagen based hemostats. On the basis on end user, the hemostats market is segmented as, hospitals & clinics, ambulatory surgical centers and others.
 
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global hemostats market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The hemostats market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting hemostats market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the hemostats market in these regions.
 
MARKET PLAYERS
The reports cover key developments in the hemostats market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from hemostats market are anticipated to lucrative growth opportunities in the future with the rising demand for hemostats in the global market. Below mentioned is the list of few companies engaged in the hemostats market.

The report also includes the profiles of key hemostats companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Johnson & Johnson Services, Inc.
  • C. R. Bard, Inc.
  • Baxter
  • B. Braun Melsungen Ag
  • Pfizer Inc.
  • Vascular Solutions, Inc.
  • Gelita Medical Gmbh
  • Integra Lifesciences Holdings Corporation
  • Equimedical B.V.
  • Z-Medica, LLC
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Hemostats Market - By Product
1.3.2. Hemostats Market - By End User
1.3.3. Hemostats Market - By Region
1.3.3.1. By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. HEMOSTATS MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis

5. HEMOSTATS MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. HEMOSTATS MARKET- GLOBAL ANALYSIS
6.1. HEMOSTATS MARKET - GLOBAL MARKET OVERVIEW
6.2. HEMOSTATS MARKET - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS

7. HEMOSTATS MARKET REVENUE AND FORECASTS TO 2027 - BY PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. THROMBIN BASED HEMOSTATS MARKET
7.3.1. Overview
7.3.2. Thrombin Based Hemostats Market Revenue Forecasts and Analysis (US$ Mn)
7.4. COMBINATION HEMOSTATS MARKET
7.4.1. Overview
7.4.2. Combination Hemostats Market Revenue Forecasts and Analysis (US$ Mn)
7.5. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET
7.5.1. Overview
7.5.2. Oxidized Regenerated Cellulose Based Hemostats Market Revenue Forecasts and Analysis (US$ Mn)
7.6. GELATIN BASED HEMOSTATS MARKET
7.6.1. Overview
7.6.2. Gelatin Based Hemostats Market Revenue Forecasts and Analysis (US$ Mn)
7.7. COLLAGEN BASED HEMOSTATS MARKET
7.7.1. Overview
7.7.2. Collagen Based Hemostats Market Revenue Forecasts and Analysis (US$ Mn)

8. HEMOSTATS MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
8.1. OVERVIEW
8.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. HOSPITALS & CLINICS MARKET
8.3.1. Overview
8.3.2. Hospitals & Clinics Market Revenue Forecasts and Analysis (US$ Mn)
8.4. AMBULATORY SURGICAL CENTERS MARKET
8.4.1. Overview
8.4.2. Ambulatory Surgical Centers Market Revenue Forecasts and Analysis (US$ Mn)
8.5. OTHER END USERS MARKET
8.5.1. Overview
8.5.2. Other End Users Market Revenue Forecasts and Analysis (US$ Mn)

9. HEMOSTATS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA HEMOSTATS MARKET
9.1.1. North America Hemostats Market Forecasts and Analysis (US$ Mn)
9.1.2. North America Hemostats Market Revenue and Forecasts Analysis - By Product (US$ Mn)
9.1.3. North America Hemostats Market Revenue and Forecasts Analysis - By End User (US$ Mn)
9.1.4. North America Hemostats Market Forecasts and Analysis - By Country
9.1.5. US Market Overview
9.1.5.1. US Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.1.5.2. US Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.1.6. Canada Market Overview
9.1.6.1. Canada Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.1.6.2. Canada Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.1.7. Mexico Market Overview
9.1.7.1. Mexico Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.1.7.2. Mexico Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.2. EUROPE HEMOSTATS MARKET
9.2.1. Europe Hemostats Market Forecasts and Analysis (US$ Mn)
9.2.2. Europe Hemostats Market Revenue and Forecasts Analysis - By Product (US$ Mn)
9.2.3. Europe Hemostats Market Revenue and Forecasts Analysis - By End User (US$ Mn)
9.2.4. Europe Hemostats Market Forecasts and Analysis - By Country
9.2.5. UK Market Overview
9.2.5.1. UK Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.2.5.2. UK Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.2.6. Germany Market Overview
9.2.6.1. Germany Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.2.6.2. Germany Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.2.7. France Market Overview
9.2.7.1. France Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.2.7.2. France Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.2.8. Italy Market Overview
9.2.8.1. Italy Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.2.8.2. Italy Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.2.9. Spain Market Overview
9.2.9.1. Spain Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.2.9.2. Spain Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.3. ASIA PACIFIC HEMOSTATS MARKET
9.3.1. Asia Pacific Hemostats Market Forecasts and Analysis (US$ Mn)
9.3.2. Asia Pacific Hemostats Market Revenue and Forecasts Analysis - By Product (US$ Mn)
9.3.3. Asia Pacific Hemostats Market Revenue and Forecasts Analysis - By End User (US$ Mn)
9.3.4. Asia Pacific Hemostats Market Forecasts and Analysis - By Country
9.3.5. China Market Overview
9.3.5.1. China Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.3.5.2. China Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.3.6. Japan Market Overview
9.3.6.1. Japan Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.3.6.2. Japan Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.3.7. India Market Overview
9.3.7.1. India Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.3.7.2. India Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.3.8. Australia Market Overview
9.3.8.1. Australia Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.3.8.2. Australia Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.3.9. South Korea Market Overview
9.3.9.1. South Korea Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.3.9.2. South Korea Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.4. MIDDLE EAST & AFRICA (MEA) HEMOSTATS MARKET
9.4.1. Middle East & Africa (MEA) Hemostats Market Forecasts and Analysis (US$ Mn)
9.4.2. Middle East & Africa (MEA) Hemostats Market Revenue and Forecasts Analysis - By Product (US$ Mn)
9.4.3. Middle East & Africa (MEA) Hemostats Market Revenue and Forecasts Analysis - By End User (US$ Mn)
9.4.4. Middle East & Africa (MEA) Hemostats Market Forecasts and Analysis - By Country
9.4.5. UAE Overview
9.4.5.1. UAE Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.4.5.2. UAE Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.4.6. Saudi Arabia Market Overview
9.4.6.1. Saudi Arabia Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.4.6.2. Saudi Arabia Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.4.7. South Africa Market Overview
9.4.7.1. South Africa Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.4.7.2. South Africa Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.5. SOUTH AND CENTRAL AMERICA HEMOSTATS MARKET
9.5.1. South and Central America Hemostats Market Forecasts and Analysis (US$ Mn)
9.5.2. South and Central America Hemostats Market Revenue and Forecasts Analysis - By Product (US$ Mn)
9.5.3. South and Central America Hemostats Market Revenue and Forecasts Analysis - By End User (US$ Mn)
9.5.4. South and Central America Hemostats Market Forecasts and Analysis - By Country
9.5.5. Brazil Market Overview
9.5.5.1. Brazil Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.5.5.2. Brazil Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.5.6. Argentina Market Overview
9.5.6.1. Argentina Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.5.6.2. Argentina Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)

12. INDUSTRY LANDSCAPE
12.1. ORGANIC GROWTH STRATEGIES
12.1.1. New Product Launches
12.1.2. Marketing & Promotional Activities
12.2. INORGANIC GROWTH STRATEGIES
12.2.1. Partnerships, Collaborations, and Joint Ventures
12.2.2. Mergers & Acquisitions

13. HEMOSTATS MARKET, KEY COMPANY PROFILES
13.1. JOHNSON & JOHNSON SERVICES, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Financial Overview
13.1.4. Product Portfolio
13.1.5. Product Pipeline
13.1.6. SWOT Analysis
13.1.7. Key Developments
13.2. C. R. BARD, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Financial Overview
13.2.4. Product Portfolio
13.2.5. Product Pipeline
13.2.6. SWOT Analysis
13.2.7. Key Developments
13.3. BAXTER
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Financial Overview
13.3.4. Product Portfolio
13.3.5. Product Pipeline
13.3.6. SWOT Analysis
13.3.7. Key Developments
13.4. B. BRAUN MELSUNGEN AG
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Financial Overview
13.4.4. Product Portfolio
13.4.5. Product Pipeline
13.4.6. SWOT Analysis
13.4.7. Key Developments
13.5. PFIZER INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Financial Overview
13.5.4. Product Portfolio
13.5.5. Product Pipeline
13.5.6. SWOT Analysis
13.5.7. Key Developments
13.6. VASCULAR SOLUTIONS, INC.
13.6.1. Business Description
13.6.2. Financial Overview
13.6.3. Product Portfolio
13.6.4. Product Pipeline
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. GELITA MEDICAL GMBH
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Financial Overview
13.7.4. Product Portfolio
13.7.5. Product Pipeline
13.7.6. SWOT Analysis
13.7.7. Key Developments
13.8. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Financial Overview
13.8.4. Product Portfolio
13.8.5. Product Pipeline
13.8.6. SWOT Analysis
13.8.7. Key Developments
13.9. EQUIMEDICAL B.V.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Financial Overview
13.9.4. Product Portfolio
13.9.5. Product Pipeline
13.9.6. SWOT Analysis
13.9.7. Key Developments
13.10.  Z-MEDICA, LLC
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Financial Overview
13.10.4. Product Portfolio
13.10.5. Product Pipeline
13.10.6. SWOT Analysis
13.10.7. Key Developments

14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS

The List of Companies

1. Johnson & Johnson Services, Inc.
2. C. R. Bard, Inc.
3. Baxter
4. B. Braun Melsungen Ag
5. Pfizer Inc.
6. Vascular Solutions, Inc.
7. Gelita Medical Gmbh
8. Integra Lifesciences Holdings Corporation
9. Equimedical B.V.
10. Z-Medica, LLC

Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book